Clin2
NCT06988826Possibly a fitNot yet recruiting

Comparing G-CSF plus antibiotics vs. antibiotics alone for fever with low white blood cells

Febrile NeutropeniaFebrile Neutropenia, Rule of Clinical Decision, ChemotherapyFebrile Neutropenia, Drug-InducedG-CSFAntibiotic Therapy

Treatments studied

Part of Blood & lymphatic clinical trials.

This trial tests whether adding a medicine called G-CSF (which helps your body make more white blood cells) to standard antibiotics works better than antibiotics alone for children with fever and low white blood cells caused by cancer treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
150 people
Ages
1 year to 16 years
Study type
Interventional

Who can take part

  • You are between 1 and 16 years old
  • You have a fever and low white blood cell count (febrile neutropenia)
  • You have been diagnosed with a solid tumor or blood cancer
  • You are currently receiving chemotherapy
  • You have not already received G-CSF or antibiotics for this fever before coming to the hospital

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05786495Recruiting
Short antibiotic treatment for high-risk fever with low white cells

This study tests whether adults with “high-risk febrile neutropenia” can safely get a shorter course of antibiotics. It may help reduce side effects from antibiotics while still keeping infections under control.

Edmonton
NCT07204522Recruiting
Antibiotic therapy for fever with low white blood cells in blood cancer

This trial tests whether an antibiotic called ceftazidime-avibactam (CAZ-AVI) can help patients with blood cancers who have a fever and very low infection-fighting white blood cells. It may be an option for people whose doctors plan to use this specific antibiotic to treat their fever.

Taiyuan, Shanxi
NCT06278896Not yet recruiting· Phase 3
Early antibiotic stopping for fever with low white blood cells

This study tests whether it's safe to stop antibiotics early in patients who have had a fever while their immune system is weak from chemotherapy. If you've been fever-free for 48 hours, you may be able to avoid unnecessary antibiotics.

NCT07277387Recruiting
Predicting complications in high-risk fever with low white blood cells

This trial studies whether proteins in your blood can predict complications when you have a fever and very low white blood cells after cancer treatment. It aims to help doctors choose the best antibiotics early on.

Barcelona, Barcelona
NCT07016165Recruiting· Phase 4
Comparing two antibiotics for fever with low white blood cells in children with blood cancer

This trial compares two antibiotics, ciprofloxacin and ceftazidime, to see which works better for treating fever in children with blood cancer who have a high risk of infection due to low white blood cells. The goal is to find the best treatment to help your child recover faster.

Sleman, DI Yogyakarta
NCT07372131Recruiting
Shorter antibiotics for high-risk fever with low white blood cells

This study looks at how long antibiotics should be given to cancer patients with fever and very low white blood cell counts after finding a certain type of bacteria (Gram-negative) in their blood. The goal is to find the best treatment duration to help patients recover without complications.

Rozzano, Milan

Hear when a new Febrile Neutropenia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.